Cardiac Safety of Kinase Inhibitors – Improving Understanding and Prediction of Liabilities in Drug Discovery Using Human Stem Cell-Derived Models
Many small molecule kinase inhibitors (SMKIs) used to combat most cancers have been related to cardiotoxicity within the clinic. Due to this fact, stopping their failure in scientific improvement is a precedence for preclinical discovery. Our examine targeted on the mixing and concurrent measurement of ATP, apoptosis dynamics and practical cardiac indexes in human stem cell-derived cardiomyocytes (hSC-CMs) to offer additional insights into...
